share_log
Reuters ·  Mar 31 13:35
Sarepta Therapeutics Down 6.2%, Beam Therapeutics Down 10.2%, U.S.-Listed Shares of CRISPR Therapeutics Down 6.2%
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 238

Recommended

Write a comment